Off-label or off-limits?

被引：0
|
作者：
Mark Ratner
Trisha Gura
机构：
[1] Trisha Gura is a Boston-based writer and former Knight fellow.,
来源：
Nature Biotechnology | 2008年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Off-label prescribing is a fundamental fact of life of healthcare systems, but the promotion of off-label uses by drug sponsors is a fundamental sin. Regulators, legislators and drug makers are wrestling to find the right balance.
引用
收藏
页码：867 / 875
页数：8
相关论文
共 50 条
12345